Andy Protter

406 total citations
7 papers, 261 citations indexed

About

Andy Protter is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Andy Protter has authored 7 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Andy Protter's work include Multiple Myeloma Research and Treatments (3 papers), Cancer Mechanisms and Therapy (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Andy Protter is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Cancer Mechanisms and Therapy (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Andy Protter collaborates with scholars based in United States, Australia and United Kingdom. Andy Protter's co-authors include George F. Schreiner, Satya Medicherla, Edmund C. Lattime, Nicola Barnard, Andressa Ardiani, Benedetto Farsaci, Partha Ray, Rongrong Ge, David Apelian and Susan R. Rittling and has published in prestigious journals such as Blood, Clinical Cancer Research and Experimental Cell Research.

In The Last Decade

Andy Protter

7 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Protter United States	5	158	150	60	50	38	7	261
Mara Mazzoni Italy	10	117 0.7×	196 1.3×	59 1.0×	62 1.2×	58 1.5×	14	330
Brad Foulk United States	6	109 0.7×	94 0.6×	67 1.1×	22 0.4×	69 1.8×	12	208
M Kůta Czechia	3	224 1.4×	205 1.4×	152 2.5×	36 0.7×	47 1.2×	5	382
Giovanni Antico United States	9	85 0.5×	147 1.0×	40 0.7×	27 0.5×	72 1.9×	12	278
Jingquan Jia United States	10	114 0.7×	116 0.8×	58 1.0×	51 1.0×	37 1.0×	28	246
Paul Swanson United States	7	212 1.3×	141 0.9×	98 1.6×	25 0.5×	37 1.0×	9	334
Elena Piñeiro-Yáñez Spain	6	61 0.4×	122 0.8×	38 0.6×	61 1.2×	98 2.6×	13	269
Elena Lasorsa United States	8	108 0.7×	177 1.2×	105 1.8×	22 0.4×	34 0.9×	11	274
Jian-chuan Xia China	10	118 0.7×	342 2.3×	39 0.7×	32 0.6×	114 3.0×	12	398
Sarit Schwartz United States	4	61 0.4×	149 1.0×	84 1.4×	36 0.7×	44 1.2×	8	211

Countries citing papers authored by Andy Protter

Since Specialization

Citations

This map shows the geographic impact of Andy Protter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Protter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Protter more than expected).

Fields of papers citing papers by Andy Protter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Protter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Protter. The network helps show where Andy Protter may publish in the future.

Co-authorship network of co-authors of Andy Protter

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Protter. A scholar is included among the top collaborators of Andy Protter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Protter. Andy Protter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Ardiani, Andressa, Benedetto Farsaci, Connie J. Rogers, et al.. (2013). Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model. Clinical Cancer Research. 19(22). 6205–6218. 71 indexed citations

Ge, Rongrong, Partha Ray, Edmund C. Lattime, et al.. (2006). Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo. Clinical Cancer Research. 12(14). 4315–4330. 123 indexed citations

Nguyen, Aaron, Elizabeth G. Stebbins, Margaret Henson, et al.. (2006). Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation. Experimental Cell Research. 312(10). 1909–1923. 49 indexed citations

Vanderkerken, Karin, Satya Medicherla, Les Coulton, et al.. (2006). Inhibition of p38α MAPK Reduces Tumor Burden, Prevents the Development of Myeloma Bone Disease, and Increases Survival in the 5T2 and 5T33 Murine Models of Myeloma.. Blood. 108(11). 3436–3436. 5 indexed citations

Omori, Keiko, Jeffrey Rawson, Kevin Ferreri, et al.. (2005). Inhibition of p38 Mitogen-Activated Protein Kinase Protects Human Islets From Cryoinjury and Improves the Yield, Viability, and Quality of Frozen-Thawed Islets. Transplantation Proceedings. 37(8). 3422–3423. 3 indexed citations

Nguyen, Aaron, Mamatha Reddy, Margaret Henson, et al.. (2004). SCIO-469, a Potent and Selective Inhibitor of p38a MAPK, Normalizes the Bone Marrow Microenvironment and Inhibits Multiple Myeloma Cell Proliferation in In Vitro and In Vivo Models.. Blood. 104(11). 1501–1501. 1 indexed citations

Levy-Wilson, Beatriz, et al.. (1984). Isolation and DNA Sequence of Full-Length cDNA for Human Preapolipoprotein CIII. DNA. 3(5). 359–364. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact